Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Interview: from Down's syndrome to basic epigenetics and back again.
Influence of rice bran stearin on stability, properties and encapsulation efficiency of polyglycerol polyricinoleate (PGPR)-stabilized water-in-rice bran oil emulsions.
Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.
A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. Reply.
See All 17 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. Reply.
Sands BE, Schreiber S, Lirio RA. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. Reply. N Engl J Med. 2020 01 02; 382(1):93-94.
View in:
PubMed
subject areas
Adalimumab
Antibodies, Monoclonal, Humanized
Colitis, Ulcerative
Humans
Infliximab